- Home
- Urologic Oncology
- CRPC w/ bone metastases
CRPC w/ bone metastases
Recent Abstracts
-
Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases.CRPC w/ bone metastasesOctober 1, 2017
-
Targeted alpha therapy of mCRPC: Dosimetry estimate of (213)Bismuth-PSMA-617.CRPC w/ bone metastasesSeptember 18, 2017
-
Radium-223 therapy of advanced metastatic castration-resistant prostate cancer: quantitative assessment of skeletal tumor burden for prognostication of clinical outcome and hematological toxicity.CRPC w/ bone metastasesSeptember 6, 2017
-
Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy.CRPC w/ bone metastasesSeptember 6, 2017
-
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.CRPC w/ bone metastasesJuly 15, 2017
-
Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer.CRPC w/ bone metastasesMay 31, 2017
-
An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223.CRPC w/ bone metastasesMay 1, 2017
-
Doped silica fibre thermoluminescence measurements of radiation dose in the use of (223)Ra.CRPC w/ bone metastasesApril 28, 2017
-
Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel.CRPC w/ bone metastasesApril 25, 2017
-
Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CTCRPC w/ bone metastasesApril 7, 2017
Beyond the Abstracts
-
Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT: Beyond the AbstractCRPC w/ bone metastasesApril 7, 2017
-
Prostate Cancer Cure is Possible: Beyond the AbstractCRPC w/ bone metastasesJanuary 5, 2017
-
The use of radium 223 dichloride in a multidisciplinary approach for treating metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Elisa BorsòCRPC w/ bone metastasesFebruary 11, 2015
E-Newsletters